Falcon-Chevere Jorge L, Mercado-Alvarado Joanna J, Ramos-Arias Yadira, Cabañas-Rivera José G
Department of Emergency Medicine, UPR School of Medicine, Puerto Rico Health Science Center, San Juan, PR.
Bol Asoc Med P R. 2009 Jul-Sep;101(3):54-7.
This 63 years old man presented to the emergency room with chest pain of more than 12 hours duration. The initial electrocardiogram showed as ST segment elevation inferior and right ventricular infarction. He developed signs and symptoms consistent with cardiogenic shock, followed by life threatening ventricular fibrillation and cardiac arrest. After repeated cardio-respiratory resuscitations and successful cardiac defibrillation, thrombolytic therapy was administered followed by clinical and hemodynamic improvements. One-week later cardiac catheterization and coronary arteriography were performed. The study showed 93% obstructive lesion in the proximal right coronary artery, an angioplasty was performed and a stent was placed. After appropriate re-adjustment of medical therapy, the patient was discharged and followed in the outpatient clinic. Although the time frame to administer thrombolytic therapy was over the 12 hours window as suggested by the AHA guidelines1, the potential risks benefits in the casepresented justifed the used of fibrinolytic therapy. Considering the multiple complications that the patient presented, fibrinolytic therapy needs to be considered even after 12 hours of symptoms initiation, particularly when facilities for primary percutaneous coronary interventions are not readily available.
这位63岁男性因持续超过12小时的胸痛被送至急诊室。初始心电图显示下壁及右心室梗死伴ST段抬高。他出现了与心源性休克相符的体征和症状,随后发生危及生命的室颤和心脏骤停。经过反复心肺复苏及成功除颤后,给予溶栓治疗,随后临床症状及血流动力学状况改善。一周后进行了心导管检查及冠状动脉造影。检查显示右冠状动脉近端有93%的阻塞性病变,进行了血管成形术并置入了支架。经过适当调整药物治疗后,患者出院并在门诊随访。尽管按照美国心脏协会指南建议,溶栓治疗的时间窗已超过12小时,但该病例中溶栓治疗潜在的风险效益证明了其使用的合理性。考虑到该患者出现的多种并发症,即使在症状出现12小时后仍需考虑溶栓治疗,尤其是在无法立即进行直接经皮冠状动脉介入治疗的情况下。